Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656822 · ClinicalTrials.gov registry record
Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 303
- Enrollment target
NCT03656822 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 303 participants.
The verdict
NCT03656822 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether adding new methods of data visualization to routine clinical care will improve (i) surgical planning and (ii) surgical outcomes in patients with kidney and prostate tumors.
Interventions
- DIAGNOSTIC_TEST Routine CT
- DIAGNOSTIC_TEST Routine imaging CT with a 3D printed model
- DIAGNOSTIC_TEST Routine imaging MRI with a 3D printed model
- DIAGNOSTIC_TEST Routine MRI
- DIAGNOSTIC_TEST Routine imaging CT with a VR model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03656822
The ClinicalTrials.gov registry entry for NCT03656822 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Routine CT is the first listed.
NCT03656822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03656822 about?
NCT03656822 is a clinical study titled "Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models". The purpose of this study is to determine whether adding new methods of data visualization to routine clinical care will improve (i) surgical planning and (ii) surgical outcomes in patients with kidney and prostate tumors.
What is the current status of trial NCT03656822?
This trial is currently completed. The enrollment target is 303 participants. The study started on 2017-02-07. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03656822?
The interventions under investigation include: Routine CT (DIAGNOSTIC_TEST), Routine imaging CT with a 3D printed model (DIAGNOSTIC_TEST), Routine imaging MRI with a 3D printed model (DIAGNOSTIC_TEST), Routine MRI (DIAGNOSTIC_TEST), Routine imaging CT with a VR model (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03656822?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.